Centrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited
Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has filed a second lawsuit against Dalas Biotech Limited (“Dalas”) for patent infringement
ROTTERDAM, The Netherlands, Oct. 18, 2019 (GLOBE NEWSWIRE) — …
Read More